We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

C. Difficile Bacteria Adapted to Spread in Hospitals

By LabMedica International staff writers
Posted on 29 Aug 2019
Clostridioides difficile, also known as Clostridium difficile, bacteria can infect the gut and are the leading cause of antibiotic-associated diarrhea worldwide. While someone is healthy and not taking antibiotics, millions of 'good' bacteria in the gut keep the C. difficile under control.

However, antibiotics wipe out the normal gut bacteria, leaving the patient vulnerable to C. difficile infection in the gut. This is then difficult to treat and can cause bowel inflammation and severe diarrhea. Often found in hospital environments, C. difficile forms resistant spores that allow it to remain on surfaces and spread easily between people, making it a significant burden on the healthcare system.

Image: The gut-infecting bacterium Clostridium difficile shown growing in a petri dish, and is evolving into two separate species with one group highly adapted to spread in hospitals (Photo courtesy of Anne Koerber/LSHTM).
Image: The gut-infecting bacterium Clostridium difficile shown growing in a petri dish, and is evolving into two separate species with one group highly adapted to spread in hospitals (Photo courtesy of Anne Koerber/LSHTM).

Scientists at the Wellcome Trust Sanger Institute (Hinxton, UK) and their colleagues collected and cultured 906 strains of C. difficile isolated from humans, animals, such as dogs, pigs and horses, and the environment. By sequencing the DNA of each strain, and comparing and analyzing all the genomes, they discovered that C. difficile is currently evolving into two separate species.

The team found that found that this emerging species, named C. difficile clade A, made up approximately 70% of the samples from hospital patients. It had changes in genes that metabolize simple sugars, so they then studied C. difficile in mice, and found that the newly emerging strains colonized mice better when their diet was enriched with sugar. It had also evolved differences in the genes involved in forming spores, giving much greater resistance to common hospital disinfectants. These changes allow it to spread more easily in healthcare environments.

Trevor Lawley, PhD, a molecular microbiologist and senior author of the study, said, “Our study provides genome and laboratory based evidence that human lifestyles can drive bacteria to form new species so they can spread more effectively. We show that strains of C. difficile bacteria have continued to evolve in response to modern diets and healthcare systems and reveal that focusing on diet and looking for new disinfectants could help in the fight against these bacteria.” The study was published on August 12, 2019, in the journal Nature Genetics.

Related Links:
Wellcome Trust Sanger Institute


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Latest Molecular Diagnostics News

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis